Nicotinic receptor–mediated protection against β-amyloid neurotoxicity
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 49 (3) , 233-239
- https://doi.org/10.1016/s0006-3223(00)01100-8
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Nicotinic α7 receptors protect against glutamate neurotoxicity and neuronal ischemic damagePublished by Elsevier ,1998
- Protective Effect of GTS-21, a Novel Nicotinic Receptor Agonist, on Delayed Neuronal Death Induced by Ischemia in GerbilsThe Japanese Journal of Pharmacology, 1998
- Low concentrations of estradiol reduce β-amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cellsBrain Research, 1997
- Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase AktScience, 1997
- GTS-21, a Nicotinic Agonist, Protects against Neocortical Neuronal Cell Loss Induced by the Nucleus Basalis Magnocellularis Lesion in Rats.The Japanese Journal of Pharmacology, 1997
- Nicotine modulates the neurotoxic effect of β-amyloid protein(25–35) in hippocampal culturesNeuroReport, 1997
- Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: A pilot double blind transdermal nicotine positron emission tomography studyNeuropsychology Review, 1996
- Aspartate neurotoxicity on cultured cortical neuronsJournal of Neuroscience Research, 1989
- Glutamate dysfunction in Alzheimer's disease: an hypothesisTrends in Neurosciences, 1987
- Smoking, nicotine and human performancePharmacology & Therapeutics, 1983